Buteyko Based Remedial Breathing Therapy With Children With Asthma
Not Applicable
Completed
- Conditions
- Asthma
- Interventions
- Behavioral: Buteyko based Remedial Breathing Therapy
- Registration Number
- NCT02140086
- Lead Sponsor
- ARCIM Institute Academic Research in Complementary and Integrative Medicine
- Brief Summary
A randomized, controlled trial to investigate the effects of a buteyko based remedial breathing therapy on children with asthma regarding to their symptoms, use of medication and lung function tests.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
- signed informed consent of the parents
- age 6- 15 years
- information and consent of the consulting doctor
- levels of asthma therapy 1-3
Exclusion Criteria
- participation in another study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Buteyko based Remedial Breathing Therapy Buteyko based Remedial Breathing Therapy Buteyko based Remedial Breathing Therapy
- Primary Outcome Measures
Name Time Method Reduction of Betamimetics (-30%) at 3- and/or 6-month follow up asthmaspezific parameters are measured before and after intervention as well as 3- and 6- month follow up
- Secondary Outcome Measures
Name Time Method Paediatric asthma caregiver´s quality of life questionnaire (PACQLQ) parameters are measured before and after intervention as well as 3- and 6- month follow up NO-measurement nasal and oral parameters are measured before and after intervention as well as 3- and 6- month follow up parameters of spirometry parameters are measured before and after intervention as well as 3- and 6- month follow up Asthma Control Questionnaire (ACQ) parameters are measured before and after intervention as well as 3- and 6- month follow up Scores of the ACQ (Asthma Control Questionnaire)
Paediatric Asthma Quality of Life Questionnaire (PAQLQ) parameters are measured before and after intervention as well as 3- and 6- month follow up Scores of PAQLQ (Paediatric Asthma Quality of Life Questionnaire)
Buteyko-Questionnaire parameters are measured before and after intervention as well as 3- and 6- month follow up ARCIM Questionnaire (AFB) parameters are measured before and after intervention as well as 3- and 6- month follow up Scores of the AFB (ARCIM Questionnaire) regarding to asthma symptoms of the last 3 month (AFB is not validated)
Peak Flow parameters are measured before and after intervention as well as 3- and 6- month follow up
Trial Locations
- Locations (1)
Filderklinik
🇩🇪Filderstadt, Baden-Württemberg, Germany